🏛️ Verified NIH Record • Updated 2025-02-10

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study (NCT06337942)

Vascularized Composite Bladder Allograft Transplantation: a Phase 0 (First-in-human) Study for Deceased Donor Bladder or Combined Kidney-bladder Transplantation

🟢 Recruiting Observational / Diagnostic 🩺 Clinical Procedure Protocol Sponsor: University of California, Los Angeles

🩺 Plain-English Summary (8th-Grade Level)

The goal of this clinical trial is to demonstrate the feasibility of bladder transplantation in patients with terminal bladder diseases who would benefit from a new bladder or a combined kidney and bladder transplant. The main questions it aims to answer are: * Is human bladder transplantation feasible and safe? * How will the new bladder function in terms of storage and emptying? Participants will undergo a bladder-only or combined kidney and bladder transplantation. They will then be followed for two years to evaluate the efficacy, safety, and functionality of the bladder transplant.

Who can join: Review the eligibility criteria below.

Location: UCLA — Los Angeles, California

Age range: 18 Years to 70 Years

🧪 Interventions in This Study

  • Bladder Transplantation (PROCEDURE)
  • Combined Kidney and Bladder Transplantation (PROCEDURE)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

  • UCLA — Los Angeles, California

📞 Contact the Study Coordinator

Phone: (310) 794-8893

Email: dlevinlopez@mednet.ucla.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Bladder Disease clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗